NM_001323289.2:c.2652C>T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_001323289.2(CDKL5):​c.2652C>T​(p.Gly884Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000154 in 1,210,414 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 60 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.00023 ( 0 hom., 6 hem., cov: 22)
Exomes 𝑓: 0.00015 ( 0 hom. 54 hem. )

Consequence

CDKL5
NM_001323289.2 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.0290

Publications

1 publications found
Variant links:
Genes affected
CDKL5 (HGNC:11411): (cyclin dependent kinase like 5) This gene is a member of Ser/Thr protein kinase family and encodes a phosphorylated protein with protein kinase activity. Mutations in this gene have been associated with X-linked infantile spasm syndrome (ISSX), also known as X-linked West syndrome, and Rett syndrome (RTT). Alternate transcriptional splice variants have been characterized. [provided by RefSeq, Jul 2008]
CDKL5 Gene-Disease associations (from GenCC):
  • CDKL5 disorder
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • developmental and epileptic encephalopathy, 2
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • atypical Rett syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • infantile spasms
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • precocious puberty
    Inheritance: XL Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BP6
Variant X-18628526-C-T is Benign according to our data. Variant chrX-18628526-C-T is described in ClinVar as [Benign]. Clinvar id is 464815.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.029 with no splicing effect.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.000232 (26/112199) while in subpopulation EAS AF = 0.00226 (8/3544). AF 95% confidence interval is 0.00112. There are 0 homozygotes in GnomAd4. There are 6 alleles in the male GnomAd4 subpopulation. Median coverage is 22. This position passed quality control check.
BS2
High AC in GnomAd4 at 26 XL,AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CDKL5NM_001323289.2 linkc.2652C>T p.Gly884Gly synonymous_variant Exon 18 of 18 ENST00000623535.2 NP_001310218.1 O76039-2
CDKL5NM_001037343.2 linkc.2652C>T p.Gly884Gly synonymous_variant Exon 19 of 22 NP_001032420.1 O76039-1
CDKL5NM_003159.3 linkc.2652C>T p.Gly884Gly synonymous_variant Exon 18 of 21 NP_003150.1 O76039-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CDKL5ENST00000623535.2 linkc.2652C>T p.Gly884Gly synonymous_variant Exon 18 of 18 1 NM_001323289.2 ENSP00000485244.1 O76039-2
CDKL5ENST00000379989.6 linkc.2652C>T p.Gly884Gly synonymous_variant Exon 19 of 22 1 ENSP00000369325.3 O76039-1
CDKL5ENST00000379996.7 linkc.2652C>T p.Gly884Gly synonymous_variant Exon 18 of 21 1 ENSP00000369332.3 O76039-1
CDKL5ENST00000674046.1 linkc.2775C>T p.Gly925Gly synonymous_variant Exon 19 of 19 ENSP00000501174.1 A0A669KBC2

Frequencies

GnomAD3 genomes
AF:
0.000232
AC:
26
AN:
112144
Hom.:
0
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.000517
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000188
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00225
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000338
AC:
62
AN:
183303
AF XY:
0.000266
show subpopulations
Gnomad AFR exome
AF:
0.000532
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00368
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000122
Gnomad OTH exome
AF:
0.000442
GnomAD4 exome
AF:
0.000147
AC:
161
AN:
1098215
Hom.:
0
Cov.:
32
AF XY:
0.000149
AC XY:
54
AN XY:
363569
show subpopulations
African (AFR)
AF:
0.000568
AC:
15
AN:
26401
American (AMR)
AF:
0.0000284
AC:
1
AN:
35207
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19386
East Asian (EAS)
AF:
0.00311
AC:
94
AN:
30206
South Asian (SAS)
AF:
0.000222
AC:
12
AN:
54148
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40531
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4137
European-Non Finnish (NFE)
AF:
0.0000356
AC:
30
AN:
842107
Other (OTH)
AF:
0.000195
AC:
9
AN:
46092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
8
15
23
30
38
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000232
AC:
26
AN:
112199
Hom.:
0
Cov.:
22
AF XY:
0.000175
AC XY:
6
AN XY:
34375
show subpopulations
African (AFR)
AF:
0.000516
AC:
16
AN:
30995
American (AMR)
AF:
0.000188
AC:
2
AN:
10634
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2650
East Asian (EAS)
AF:
0.00226
AC:
8
AN:
3544
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2691
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6084
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
217
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
53188
Other (OTH)
AF:
0.00
AC:
0
AN:
1514
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000142
Hom.:
0
Bravo
AF:
0.000487
EpiCase
AF:
0.0000545
EpiControl
AF:
0.000119

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Sep 21, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Developmental and epileptic encephalopathy, 2;CN128785:Angelman syndrome-like Benign:1
Jan 28, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.77
CADD
Benign
1.2
DANN
Benign
0.66
PhyloP100
0.029
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201473442; hg19: chrX-18646646; COSMIC: COSV66111355; COSMIC: COSV66111355; API